| ?? |
?? ?? |
CAS |
MF |
 |
A419259???? |
364042-47-7 |
C29H34N6O |
 |
AZM 475271 |
476159-98-5 |
C23H27ClN4O3 |
 |
FostaMatinib DisodiuM Hexahydrate |
914295-16-2 |
C23H24FN6Na2O9P |
 |
SN 2 |
|
|
 |
S-(2-?????)-L-??????? |
222638-67-7 |
C5H13BClNO4S |
 |
Y-27632????? |
146986-50-7 |
C14H21N3O |
 |
(S)-(+)-????? |
51146-56-6 |
C13H18O2 |
 |
6-???-7-???????-2,3-?? |
115066-14-3 |
C9H4N4O4 |
 |
BRL52537??? |
130497-33-5 |
C18H24Cl2N2O |
 |
4-(3'-??????)???-6,7-????????,HCL |
153437-55-9 |
C16H16ClN3O3 |
 |
??60-7550 |
439083-90-6 |
C27H32N4O4 |
 |
?????? |
58895-64-0 |
C21H26ClNO3 |
 |
??????????? |
73232-52-7 |
C21H26BrNO4 |
 |
????? |
85175-67-3 |
C26H36N2O5 |
 |
???? |
211867-47-9 |
C21H22FNO4 |
 |
??????? |
5581-42-0 |
C15H16ClN3O3S |
 |
????? |
88058-88-2 |
C15H21NO2 |
 |
??? |
85604-00-8 |
C8H10N6S |
 |
PT-2385 |
1672665-49-4 |
C17H12F3NO4S |
 |
GlyT2-IN-1 |
448947-81-7 |
C13H8Cl2N4S2 |
 |
MCB-613 |
1162656-22-5 |
C20H20N2O |
 |
LLY-507 |
1793053-37-8 |
C36H42N6O |
 |
ETC-159 |
1638250-96-0 |
C19H17N7O3 |
 |
NU6300 |
2070015-09-5 |
C20H23N5O3S |
 |
?????? |
415903-37-6 |
C26H29N5O3S |
 |
1627710-50-2 |
1627710-50-2 |
C22H21F2N3O |
 |
CC-115(???) |
1300118-55-1 |
C16H17ClN8O |
 |
C-DIM12 |
178946-89-9 |
C23H17ClN2 |
 |
GSK-3326595 |
1616392-22-3 |
C24H32N6O3 |
 |
Selonsertib |
1448428-04-3 |
C24H24FN7O |
 |
Orexin 2 Receptor Agonist |
1796565-52-0 |
C32H34N4O5S |
 |
ML264 |
1550008-55-3 |
C17H21ClN2O4S |
 |
GSK481 |
1622849-58-4 |
C21H19N3O4 |
 |
SZL P1-41 |
222716-34-9 |
C24H24N2O3S |
 |
BFH772 |
890128-81-1 |
C23H16F3N3O3 |
 |
Lp-PLA2 -IN-1 |
1420367-28-7 |
C21H17F5N4O3 |
 |
NSC23005 Sodium |
1796596-46-7 |
C13H18NNaO4S |
 |
Futibatinib |
1448169-71-8 |
C22H22N6O3 |
 |
MKC3946 |
1093119-54-0 |
C21H20N2O3S |
 |
9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one |
851107-28-3 |
C33H34ClNO3 |
 |
Pimodivir |
1629869-44-8 |
C20H19F2N5O2 |
 |
??????? |
107097-80-3 |
C21H30Cl2N2O5 |
 |
???????? |
138452-21-8 |
C32H40ClNO4 |
 |
????? |
808-26-4 |
C21H22N2O7 |
 |
??????? |
1163-36-6 |
C19H21Cl2N3 |
 |
??????? |
82-98-4 |
C21H25NO2 |
 |
????? |
313348-27-5 |
C15H18N8O5 |
![Benzo[b]thiophene-2-butanoic acid, 5,6-dimethoxy-α-methyl-γ-oxo-, (αS)-](/CAS/20210305/GIF/2218504-06-2.gif) |
Benzo[b]thiophene-2-butanoic acid, 5,6-dimethoxy-α-methyl-γ-oxo-, (αS)- |
2218504-06-2 |
C15H16O5S |
 |
3,4-Pyrrolidinediol, 2-(4-amino-5H-pyrrolo3,2-dpyrimidin-7-yl)-5-(hydroxymethyl)-, monohydrochloride, (2S,3S,4R,5R)- |
222631-44-9 |
C11H16ClN5O3 |
|
|
ODN D-SL01 |
1198621-84-9 |
|
 |
2-???-3-(1-????-3-?)?????? |
56396-35-1 |
C18H12N2O2 |
![2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)-](/CAS2/GIF/1026016-83-0.gif) |
2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, (3R,11bR)- |
1026016-83-0 |
C19H27NO3 |
 |
?????? |
170105-16-5 |
C20H21N3O |
 |
Teneligliptin |
760937-92-6 |
C22H30N6OS |
 |
????? |
96187-53-0 |
C23H15F2NO2 |
 |
????? |
34839-70-8 |
C9H16N4S2 |
 |
D-??? |
98201-93-5 |
C6H14O6 |
 |
AGN 194310 |
229961-45-9 |
C28H24O2S |
 |
3-(2,4-????????)????? |
156223-05-1 |
C19H22Cl2N2O2 |
 |
?????? |
1568-80-5 |
C21H24O2 |
 |
LHRH(???III) |
147859-97-0 |
C59H74N18O14 |
 |
???? |
453562-69-1 |
C22H23N5O |
 |
???????? |
275371-94-3 |
C152H232N40O45 |
![Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)Methoxy]-](/CAS/GIF/530141-72-1.gif) |
Benzenepropanoic acid, 5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(2,3-dihydro-3-oxo-1,2-benzisoxazol-6-yl)Methoxy]- |
530141-72-1 |
C29H27NO8 |
 |
Alectinib Hydrochloride |
1256589-74-8 |
C30H35ClN4O2 |
 |
???? |
1192500-31-4 |
C7H11N3O6S |
 |
ATN-161 |
262438-43-7 |
C23H35N9O8S |
 |
Ipragliflozin |
761423-87-4 |
C21H21FO5S |
 |
(2'R)- 2'-Deoxy-2'-fluoro-2'-methylcytidine 3',5'-bis(2-methylpropanoate) |
940908-79-2 |
C18H26FN3O6 |
 |
TPPU |
1222780-33-7 |
C16H20F3N3O3 |
 |
GW1929 |
196808-24-9 |
C30H29N3O4 |
 |
5-(5-(2-(3-aMinopropoxy)-6-Methoxyphenyl)-1H-pyrazol-3-ylaMino)pyrazine-2-carbonitrile hydrochloride |
1234015-54-3 |
C18H21Cl2N7O2 |
 |
??0991 |
304462-19-9 |
C29H32N4O5S2 |
 |
Dalbavancin???–A40926-B0 |
102961-72-8 |
C83H86Cl2N8O30 |
 |
?????(???) |
1198769-38-8 |
C37H44F2N8O5 |
 |
GSK-3???1 |
603272-51-1 |
C22H17ClFN5O2 |
 |
Mutant IDH1 inhibitor |
1429180-08-4 |
C25H34N6O3 |
 |
SDZ220-581(???) |
179411-93-9 |
C16H18Cl2NO5P |
 |
PTC-209 (PTC209 |
315704-66-6 |
C17H13Br2N5OS |
 |
???6(???) |
1011301-29-3 |
C25H35ClN4O2S |
 |
(R)-1-(3,6-dibroMo-9H-carbazol-9-yl)-3-(3-MethoxyphenylaMino)propan-2-ol |
1235481-43-2 |
C22H20Br2N2O2 |
![(S)-3-(aMinoMethyl)-7-(3-hydroxypropoxy)benzo[c][1,2]oxaborol-1(3H)-ol](/CAS/20150408/GIF/1234563-16-6.gif) |
(S)-3-(aMinoMethyl)-7-(3-hydroxypropoxy)benzo[c][1,2]oxaborol-1(3H)-ol |
1234563-16-6 |
C11H16BNO4 |
 |
K-Ras G12C-IN-1 |
1629265-17-3 |
C22H23Cl2N3O3 |
 |
MAChR-IN-1 |
119391-56-9 |
C23H25IN2O2 |
 |
FMoc-?-Cit-PAB |
159858-22-7 |
C33H39N5O6 |
![K-7174, 1,4-Bis[5-(3,4,5-triMethoxyphenyl)-4(E)-pentenyl]hexahydro-1H-1,4-diazepine](/CAS/GIF/191089-60-8.gif) |
K-7174, 1,4-Bis[5-(3,4,5-triMethoxyphenyl)-4(E)-pentenyl]hexahydro-1H-1,4-diazepine |
191089-60-8 |
C33H48N2O6 |
 |
DBPR108 |
1186426-66-3 |
C16H25FN4O2 |
 |
OTS964 hydrochloride |
1338545-07-5 |
C23H24N2O2S |
![7-nitro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione](/CAS/20180629/GIF/73043-80-8.gif) |
7-nitro-1-methyl-1H-benzo[d][1,3]oxazine-2,4-dione |
73043-80-8 |
C9H6N2O5 |
 |
TH588 |
1609960-31-7 |
C13H12Cl2N4 |
 |
SEP-0372814 |
1516895-53-6 |
C21H19N7 |
 |
RI-2 |
1417162-36-7 |
C21H18Cl2N2O4 |
 |
1,1,2,2-??????-1,2-?????? |
76-12-0 |
C2Cl4F2 |
 |
2-???-1,4-????? |
2348-82-5 |
C11H8O3 |
 |
LDN-212320 |
894002-50-7 |
C17H15N3S |
![2,4-????-N-?????-N-[2-(????????)??]???????](/CAS/GIF/946387-07-1.gif) |
2,4-????-N-?????-N-[2-(????????)??]??????? |
946387-07-1 |
C14H22Cl2N2O2S |
 |
4-IBP |
155798-08-6 |
C19H21IN2O |
 |
????? |
239101-33-8 |
C11H11NO4S |
 |
4,4'-???????? |
2479-49-4 |
C17H10O9 |
 |
?????? |
13636-18-5 |
C23H26ClN |